Reflecting AFIPA’s shift towards selfcare products (medicines, medical devices and self-medication food supplements), AFIPA (the French Federation of the Pharmaceutical Industry for Responsible Self-Medication) has for the first time published the 2013 figures for this market. Carried out by Celtipharm, the 12th Barometer shows an imbalance between self-medication drugs on the one hand and medical devices and food supplements on sale in pharmacies on the other.
Total sales of self-medication drugs, at retail price and including VAT, amounted to €2.123 billion in 2013, a 3% decline compared to 2012. In contrast, medical devices and food supplements experienced more favourable conditions, with an increase in sales of 4.3% and 6.2% respectively.
 The selfcare products represented by Afipa are aimed at individuals who wish to play a role in their own health care or well-being, generally speaking with the advice of a health care professional. They include medicines for which a medical prescription is optional and which are not reimbursed, medical devices (for which a prescription is optional or unnecessary and which are not reimbursed) and food supplements (available without a prescription).
To read the press release :